SPONSORED:

NIH to make announcement on fetal tissue research policy amid Trump-era restrictions

NIH to make announcement on fetal tissue research policy amid Trump-era restrictions
© Getty Images

The National Institutes of Health (NIH) plans to make an announcement on its fetal tissue research policy following a Trump administration ban, Health and Human Services (HHS) Secretary Xavier BecerraXavier BecerraMcDonald's teams up with HHS on pro-vaccination campaign Overnight Health Care: FDA authorizes Pfizer vaccine for adolescents | Biden administration reverses limits on LGBTQ health protections The Hill's 12:30 Report - Presented by Facebook - Biden reverses Trump limits on transgender protections MORE said on Thursday. 

During a House Appropriations subcommittee hearing, Becerra said NIH “will be making an announcement I believe tomorrow” on the ban implemented in 2019.

“You want to keep your ears open for that,” he said. “But we believe that we have to do the research that it takes to make sure that we’re incorporating innovation and getting all of those types of treatments and therapies out there to the American people.”

ADVERTISEMENT

Later in the hearing, Rep. Ben ClineBenjamin (Ben) Lee ClineGOP votes to dump Cheney from leadership Virginia GOP set for wild, unpredictable convention Garland emphasizes national security, civil rights in budget hearing MORE (R-Va.) said, “I hope you're going to continue the Trump administration policy and that's going to be your announcement tomorrow.”

But the upcoming notice on fetal tissue research comes after 26 Democratic House members sent a letter to Becerra earlier this week calling for the Biden administration to end the Trump-era restriction. 

The letter, led by Democratic Reps. Suzan DelBeneSuzan Kay DelBeneDemocrats renew push for permanent child credit expansion Democrats signal House bill to go further than Biden proposal on child tax credit Democratic scramble complicates Biden's human infrastructure plan MORE (Wash.), Jan SchakowskyJanice (Jan) Danoff SchakowskyBattle lines drawn over Biden's support for vaccine waivers Overnight Health Care: Biden sets goal of at least one shot to 70 percent of adults by July 4 | White House to shift how it distributes unallocated vaccines to states Pressure builds for Biden to back vaccine patent waivers MORE (Ill.), and Mark PocanMark William PocanProgressives divided over efforts to repeal SALT cap Left feels empowered after Biden backtracks on refugees NIH reverses Trump administration's ban on fetal tissue research MORE (Wis.), labeled fetal tissue as “an irreplaceable resource for research that has led to numerous scientific and medical advances,” including treatment for COVID-19.

“The previous administration’s restrictions on fetal tissue research continue to threaten scientific and medical advances by blocking intramural researchers from using the material and discouraging extramural researchers from pursuing research with it,” the lawmakers wrote. “The Trump administration’s policy was politically motivated and unnecessary.”

The Democrats also said that fetal tissue has been used to treat cystic fibrosis and hemophilia and has assisted in studying Zika, HIV, ALS and Parkinson’s disease. Supporters of using fetal tissue in research have said it’s been used for decades, including in creating the first polio and measles vaccines. 

ADVERTISEMENT

Then-President TrumpDonald TrumpGOP-led Maricopa County board decries election recount a 'sham' Analysis: Arpaio immigration patrol lawsuit to cost Arizona county at least 2 million Conservatives launch 'anti-cancel culture' advocacy organization MORE faced pressure from anti-abortion organizations to stop allowing federal funding to go to research projects that use fetal tissue from elective abortions. The former president announced the ban in June 2019, as well as the cancellation of a multimillion-dollar contract with the University of California, San Francisco, which used fetal tissue in HIV studies.  

"Promoting the dignity of human life from conception to natural death is one of the very top priorities of President Trump’s administration," HHS said in a statement at the time. 

House Democrats responded that same month with a vote to block the ban. But the measure did not go anywhere in the Republican-majority Senate. 

Several Democratic members also requested that Trump rescind the ban amid the COVID-19 pandemic in April of last year, so federal funding could go to research on treatments involving fetal tissues.